Home › Cancro alla prostata › Michigan › Detroit
Studi clinici su Cancro alla prostata a Detroit, MI
22 studi su Cancro alla prostata cercano partecipanti presso sedi a Detroit e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Vanguard Study: Testing a New Way to Screen for Cancer
In reclutamentoVolontari sani benvenuti
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
In reclutamentoFase 3
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
In reclutamentoFase 3
- Henry Ford Hospital ( Site 0015), Detroit
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
In reclutamentoFase 1/2
- Research Site, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
In reclutamentoFase 3
- Karmanos Cancer Institute, Detroit
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
In reclutamentoFase 3
- Henry Ford Hospital ( Site 0035), Detroit
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
In reclutamento
- Wayne State University, Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
In reclutamentoFase 3
- Henry Ford Hospital, Detroit
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
In reclutamentoFase 1/2
- Karmanos Cancer Institute, Detroit
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
In reclutamentoFase 1
- Karmanos, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
In reclutamento
- Karmanos Cancer Institute, Detroit
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
In reclutamentoStudio osservazionale
- Karmanos Cancer Institute, Detroit
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
In reclutamentoFase 1/2
- Karmanos Cancer Institute, Detroit
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
In reclutamentoFase 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
In reclutamentoFase 3
- Henry Ford Health Saint John Hospital, Detroit
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
In reclutamento
- Henry Ford Health, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site 129, Detroit
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Detroit
- Cancro del polmone non a piccole cellule44 studi
- Cancro al seno33 studi
- Cancro (tutti i tipi)29 studi
- Cancro colorettale26 studi
- Cancro ovarico26 studi
- Cancro metastatico24 studi
- Cancro dell'endometrio21 studi
- Cancro ai polmoni20 studi
- Mieloma multiplo19 studi
- Cancro dello stomaco16 studi
- Carcinoma a cellule squamose della testa e del collo15 studi
- Leucemia mieloide acuta14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.